Synageva BioPharma to Present at the Cowen and Company 33rd Annual Health Care Conference

Published: Feb 26, 2013

Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today announced its presentation at the upcoming Cowen and Company 33rd Annual Health Care Conference.

Back to news